Nevada
Fee-For-Service Medicaid Coverage of Screening
Covered and Using Updated Guidelines
Highlighted Disparity
Data by race/ethnicity are not available for Nevada.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Nevada is not available over this period.
5-Year Survival Rate:
- The percent of people still alive five years after being diagnosed with lung cancer (the survival rate) is 26.6% nationally.
- Nevada is one of the 9 states for which survival data is not available as they do not track cases after diagnosis.
Early Diagnosis:
- The early diagnosis rate is not available for Nevada due to data limitations.
Lung Cancer Treatment
Surgical Treatment:
- Nationally, 20.8% of cases undergo surgery as part of the first course of treatment.
- Data on surgery as part of the first course of treatment is not available for Nevada.
Lack of Treatment:
- Nationally, 20.6% of cases receive no treatment.
- Data on lack of treatment is not available for Nevada.
Screening
Screening for High Risk:
- In Nevada, 1.4% of those at high risk were screened, which was significantly lower than the national rate of 4.5%.
- It ranks 47th among all states, placing it in the bottom tier.
- Actual screening rates may be higher in states with large, regional managed care providers that did not share screening data.
Medicaid Coverage:
- Nevada was one of the 49 states whose Medicaid fee-for-service programs covered lung cancer screening as of October 2023.
- While their program did not require prior authorization or copays, it did not use recommended guidelines for determining eligibility.
Prevention
Tobacco Use:
- The smoking rate in Nevada is 15.5% and not significantly different than the national rate of 13.5%.
- It ranks 35th among all states, placing it in the below average tier.
Radon:
- In Nevada, 12.8% of radon tests results were at or above the action level recommended by EPA.
- It ranks 12th among all states, placing it in the above average tier.
Racial & Ethnic Disparities
Black individuals:
- Lung cancer rates are not available Nevada for this period.
Latino individuals:
- Lung cancer rates are not available Nevada for this period.
Asian Americans or Pacific Islanders:
- Lung cancer rates are not available Nevada for this period.
Indigenous Peoples:
- Lung cancer rates are not available Nevada for this period.
Summary
Early diagnosis data is not available for Nevada. When this rate increases, we can anticipate that the surgery rate would increase, as surgery is often the recommended treatment for those diagnosed at an earlier stage. In addition, when cases are found earlier, we would expect the five-year survival rate to increase.
Nevada has improved access to expanded screening by covering it through its fee-for-service Medicaid program. The Lung Association encourages all states to cover lung cancer screening based on the latest guidelines across all fee-for-service and managed care plans without any financial or administrative barriers in their Medicaid programs.